Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9572871 High frequency application of botulinum toxin therapy

Patent 9572871 was granted and assigned to Merz Pharma on February, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Susanne Grafe0

Dirk Dressler0

Matthias Marx0

Reiner Benecke0

Date of Patent

February 21, 2017

0

Patent Application Number

147498340

Date Filed

June 25, 2015

0

Patent Primary Examiner

Nita M. Minnifield

0

Patent abstract

The present invention relates to methods for treating diseases and disorders by administering a composition containing the neurotoxic component of a Clostridium botulinum toxin complex, wherein the composition is devoid of any other protein of the Clostridium botulinum toxin complex and wherein the composition is administered at short intervals and/or in high doses.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9572871 High frequency application of botulinum toxin therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.